Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
Identifieur interne : 001627 ( Main/Exploration ); précédent : 001626; suivant : 001628Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
Auteurs : S. Fuchs [Israël] ; G. Gat-Yablonski [Israël] ; B. Shtaif [Israël] ; L. Lazar [Israël] ; M. Phillip [Israël] ; Y. Lebenthal [Israël]Source :
- Journal of endocrinological investigation [ 1720-8386 ] ; 2015.
Descripteurs français
- KwdFr :
- Adolescent, Enfant, Enfant d'âge préscolaire, Facteur de croissance IGF-I (analyse), Facteur de croissance endothéliale vasculaire de type A (sang), Facteur de croissance endothéliale vasculaire de type C (sang), Hormone de croissance humaine (administration et posologie), Hormone de croissance humaine (pharmacologie), Humains, Lymphoedème (sang), Lymphoedème (traitement médicamenteux), Mâle, Résultat thérapeutique, Syndrome de Noonan (sang), Syndrome de Noonan (traitement médicamenteux), Études rétrospectives.
- MESH :
- administration et posologie : Hormone de croissance humaine.
- analyse : Facteur de croissance IGF-I.
- pharmacologie : Hormone de croissance humaine.
- sang : Facteur de croissance endothéliale vasculaire de type A, Facteur de croissance endothéliale vasculaire de type C, Lymphoedème, Syndrome de Noonan.
- traitement médicamenteux : Lymphoedème, Syndrome de Noonan.
- Adolescent, Enfant, Enfant d'âge préscolaire, Humains, Mâle, Résultat thérapeutique, Études rétrospectives.
English descriptors
- KwdEn :
- Adolescent, Child, Child, Preschool, Human Growth Hormone (administration & dosage), Human Growth Hormone (pharmacology), Humans, Insulin-Like Growth Factor I (analysis), Lymphedema (blood), Lymphedema (drug therapy), Male, Noonan Syndrome (blood), Noonan Syndrome (drug therapy), Retrospective Studies, Treatment Outcome, Vascular Endothelial Growth Factor A (blood), Vascular Endothelial Growth Factor C (blood).
- MESH :
- chemical , administration & dosage : Human Growth Hormone.
- chemical , analysis : Insulin-Like Growth Factor I.
- chemical , blood : Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor C.
- chemical , pharmacology : Human Growth Hormone.
- blood : Lymphedema, Noonan Syndrome.
- drug therapy : Lymphedema, Noonan Syndrome.
- Adolescent, Child, Child, Preschool, Humans, Male, Retrospective Studies, Treatment Outcome.
Abstract
Noonan syndrome (NS) is characterized by short stature and elevated risk of lymphedema. The mechanism underlying lymphedema may be mediated by vascular endothelial growth factors (VEGFs).
DOI: 10.1007/s40618-014-0194-2
PubMed: 25344824
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001237
- to stream PubMed, to step Curation: 001237
- to stream PubMed, to step Checkpoint: 001237
- to stream Ncbi, to step Merge: 006C53
- to stream Ncbi, to step Curation: 006C53
- to stream Ncbi, to step Checkpoint: 006C53
- to stream Main, to step Merge: 001629
- to stream Main, to step Curation: 001627
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.</title><author><name sortKey="Fuchs, S" sort="Fuchs, S" uniqKey="Fuchs S" first="S" last="Fuchs">S. Fuchs</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Gat Yablonski, G" sort="Gat Yablonski, G" uniqKey="Gat Yablonski G" first="G" last="Gat-Yablonski">G. Gat-Yablonski</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Shtaif, B" sort="Shtaif, B" uniqKey="Shtaif B" first="B" last="Shtaif">B. Shtaif</name><affiliation wicri:level="1"><nlm:affiliation>Felsenstein Medical Research Center, 49100, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Felsenstein Medical Research Center, 49100, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Lazar, L" sort="Lazar, L" uniqKey="Lazar L" first="L" last="Lazar">L. Lazar</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Phillip, M" sort="Phillip, M" uniqKey="Phillip M" first="M" last="Phillip">M. Phillip</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Lebenthal, Y" sort="Lebenthal, Y" uniqKey="Lebenthal Y" first="Y" last="Lebenthal">Y. Lebenthal</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel. yael_lebenthal@walla.co.il.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25344824</idno><idno type="pmid">25344824</idno><idno type="doi">10.1007/s40618-014-0194-2</idno><idno type="wicri:Area/PubMed/Corpus">001237</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001237</idno><idno type="wicri:Area/PubMed/Curation">001237</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001237</idno><idno type="wicri:Area/PubMed/Checkpoint">001237</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001237</idno><idno type="wicri:Area/Ncbi/Merge">006C53</idno><idno type="wicri:Area/Ncbi/Curation">006C53</idno><idno type="wicri:Area/Ncbi/Checkpoint">006C53</idno><idno type="wicri:Area/Main/Merge">001629</idno><idno type="wicri:Area/Main/Curation">001627</idno><idno type="wicri:Area/Main/Exploration">001627</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.</title><author><name sortKey="Fuchs, S" sort="Fuchs, S" uniqKey="Fuchs S" first="S" last="Fuchs">S. Fuchs</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Gat Yablonski, G" sort="Gat Yablonski, G" uniqKey="Gat Yablonski G" first="G" last="Gat-Yablonski">G. Gat-Yablonski</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Shtaif, B" sort="Shtaif, B" uniqKey="Shtaif B" first="B" last="Shtaif">B. Shtaif</name><affiliation wicri:level="1"><nlm:affiliation>Felsenstein Medical Research Center, 49100, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Felsenstein Medical Research Center, 49100, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Lazar, L" sort="Lazar, L" uniqKey="Lazar L" first="L" last="Lazar">L. Lazar</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Phillip, M" sort="Phillip, M" uniqKey="Phillip M" first="M" last="Phillip">M. Phillip</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Lebenthal, Y" sort="Lebenthal, Y" uniqKey="Lebenthal Y" first="Y" last="Lebenthal">Y. Lebenthal</name><affiliation wicri:level="1"><nlm:affiliation>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva, Israel. yael_lebenthal@walla.co.il.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 14 Kaplan Street, 49202, Petah Tikva</wicri:regionArea><wicri:noRegion>Petah Tikva</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of endocrinological investigation</title><idno type="eISSN">1720-8386</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Child</term><term>Child, Preschool</term><term>Human Growth Hormone (administration & dosage)</term><term>Human Growth Hormone (pharmacology)</term><term>Humans</term><term>Insulin-Like Growth Factor I (analysis)</term><term>Lymphedema (blood)</term><term>Lymphedema (drug therapy)</term><term>Male</term><term>Noonan Syndrome (blood)</term><term>Noonan Syndrome (drug therapy)</term><term>Retrospective Studies</term><term>Treatment Outcome</term><term>Vascular Endothelial Growth Factor A (blood)</term><term>Vascular Endothelial Growth Factor C (blood)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteur de croissance IGF-I (analyse)</term><term>Facteur de croissance endothéliale vasculaire de type A (sang)</term><term>Facteur de croissance endothéliale vasculaire de type C (sang)</term><term>Hormone de croissance humaine (administration et posologie)</term><term>Hormone de croissance humaine (pharmacologie)</term><term>Humains</term><term>Lymphoedème (sang)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Syndrome de Noonan (sang)</term><term>Syndrome de Noonan (traitement médicamenteux)</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Human Growth Hormone</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Insulin-Like Growth Factor I</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Vascular Endothelial Growth Factor A</term><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Human Growth Hormone</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Hormone de croissance humaine</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Facteur de croissance IGF-I</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Lymphedema</term><term>Noonan Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term><term>Noonan Syndrome</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Hormone de croissance humaine</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type A</term><term>Facteur de croissance endothéliale vasculaire de type C</term><term>Lymphoedème</term><term>Syndrome de Noonan</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term><term>Syndrome de Noonan</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Child</term><term>Child, Preschool</term><term>Humans</term><term>Male</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Humains</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Noonan syndrome (NS) is characterized by short stature and elevated risk of lymphedema. The mechanism underlying lymphedema may be mediated by vascular endothelial growth factors (VEGFs).</div></front></TEI><affiliations><list><country><li>Israël</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Fuchs, S" sort="Fuchs, S" uniqKey="Fuchs S" first="S" last="Fuchs">S. Fuchs</name></noRegion><name sortKey="Gat Yablonski, G" sort="Gat Yablonski, G" uniqKey="Gat Yablonski G" first="G" last="Gat-Yablonski">G. Gat-Yablonski</name><name sortKey="Lazar, L" sort="Lazar, L" uniqKey="Lazar L" first="L" last="Lazar">L. Lazar</name><name sortKey="Lebenthal, Y" sort="Lebenthal, Y" uniqKey="Lebenthal Y" first="Y" last="Lebenthal">Y. Lebenthal</name><name sortKey="Phillip, M" sort="Phillip, M" uniqKey="Phillip M" first="M" last="Phillip">M. Phillip</name><name sortKey="Shtaif, B" sort="Shtaif, B" uniqKey="Shtaif B" first="B" last="Shtaif">B. Shtaif</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001627 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001627 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25344824
|texte= Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25344824" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |